Literature DB >> 4388368

The pharmacology of parkinsonism (a review).

H L Klawans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4388368

Source DB:  PubMed          Journal:  Dis Nerv Syst        ISSN: 0012-3714


× No keyword cloud information.
  18 in total

1.  Effects of desipramine on neuronal responses to dopamine, noradrenaline, 5-hydroxytryptamine and acetylcholine in the caudate nucleus of the rat.

Authors:  P Bevan; C M Bradshaw; E Szabadi
Journal:  Br J Pharmacol       Date:  1975-07       Impact factor: 8.739

2.  Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs.

Authors:  J R Blackburn; A G Phillips
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Opposing effects of dopaminergic to cholinergic compounds on a cerebral dopamine-activated adenylate cyclase.

Authors:  L C Tang; G C Cotzias
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  Dopaminergic inhibition of striatal cholinergic neurons: synergistic blocking action of gamma-butyrolactone and neuroleptic drugs.

Authors:  H Stadler; K G Lloyd; G Bartholini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

Review 5.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 6.  Dopamine and disease.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1970-10-17       Impact factor: 8.262

7.  Treatment of blepharospasm with levodopa.

Authors:  N K Chakravorty
Journal:  Postgrad Med J       Date:  1974-08       Impact factor: 2.401

8.  The effects of anti-Parkinson drugs on cortical neurones.

Authors:  G Clarke; J Davies
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739

9.  L-dopa and the negative symptoms of Parkinsonism.

Authors:  H L Klawans; M Erlich
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-10       Impact factor: 10.154

10.  Alteration of basal ganglia evoked responses by reserpine and L-dopa.

Authors:  W C Koller; C A Berry
Journal:  Psychopharmacology (Berl)       Date:  1976-09-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.